Evidence map›Paper›PMID 39901315›Full record

ArticleDrug and alcohol review2025

First episode of catatonia followed by a psychotic episode related to chronic nitrous oxide use: A case report.

Tanguy Taillefer de Laportalière, Maximilien Redon, Anne Roussin, Estelle Willemet, Etienne Very, Jean Olivier, Maryse Lapeyre-Mestre

Abstract readCase Reports
In one paragraph

Article in Drug and alcohol review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Psychosis Related to Nitrous Oxide Misuse: A Case Series and Systematic Review.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2026
    Review
  2. Catatonia induced by nitrous oxide anesthesia in a healthy adolescent: A case report.PCN reports : psychiatry and clinical neurosciences · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tanguy Taillefer de LaportalièreDepartment of Pharmacy, Toulouse University Hospital, Toulouse, France.ORCID 0000-0002-0173-6437
Maximilien RedonDepartment of Emergency, Crisis and Liaison Psychiatry, Toulouse University Hospital, Toulouse, France.
Anne RoussinDepartment of Medical and Clinical Pharmacology, Addictovigilance Centre, Toulouse University Hospital, University of Toulouse, Toulouse, France.
Estelle WillemetDepartment of Emergency, Crisis and Liaison Psychiatry, Toulouse University Hospital, Toulouse, France.
Etienne VeryDepartment of Psychiatry, Psychotherapy, and Art Therapy, Toulouse University Hospital, Toulouse, France.
Jean OlivierDepartment of Emergency, Crisis and Liaison Psychiatry, Toulouse University Hospital, Toulouse, France.
Maryse Lapeyre-MestreDepartment of Medical and Clinical Pharmacology, Addictovigilance Centre, Toulouse University Hospital, University of Toulouse, Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNitrous oxide is widely used for recreational purposes, leading to constantly increasing cases of severe use disorder. Although the scope of the deleterious consequences of nitrous oxide use is relatively well described for neurological and thromboembolic-related complications, this is not the case in the psychiatric field. CASE PRESENTATION: We report the case of a 20-year-old woman who developed nitrous oxide-induced peripheral neuropathy. The patient had a history of frequent nitrous oxide use. One year later, she presented with catatonia linked to nitrous oxide use, associated with vitamin B12 deficiency and hyperhomocysteinemia, with no apparent psychiatric causes. Nine months after the catatonic episode, she experienced a psychotic episode linked to long-term nitrous oxide use. DISCUSSION AND

conclusionTo the best of our knowledge, this is the first report describing a cascade of neurologic and psychiatric complications of chronic use of nitrous oxide. Hyperhomocysteinemia caused by nitrous oxide consumption could explain the occurrence of such events. Homocysteine, methylmalonic acid, and active vitamin B12 are key biomarkers to determine the involvement of nitrous oxide in psychiatric symptoms.

Indexed as

CatatoniaNitrous OxidePsychoses, Substance-InducedPsychotic DisordersFemaleHumansHyperhomocysteinemiaVitamin B 12 DeficiencyYoung AdultNitrous Oxidecatatonianitrous oxidesubstance‐related disorders

Identifiers

PMID39901315
PMCPMC11886473

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.